10q10k10q10k.net
UNITED THERAPEUTICS Corp

UNITED THERAPEUTICS CorpUTHREarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; ...

Top Holders

Holder% OwnedSharesChangeAs of
BlackRock, Inc.11.30%
5.3M
—2024-01-24
The Vanguard Group10.57%
4.7M
▲ +0.62pp2024-06-10
Wellington Management Group LLP8.07%
3.8M
▼ -1.94pp2024-02-08
Nos. of Above Person6.80%
3.2M
▼ -1.00pp2024-11-08
Avoro Capital Advisors LLC6.10%
2.9M
—2024-02-14
STATE STREET CORPORATION5.00%
2.2M
—2024-10-16
FMR LLC4.94%
2.3M
—2024-02-09
NOS. OF ABOVE PERSONS4.62%
2.2M
▲ +0.51pp2024-02-13

Insider Transactions

Net 90d: −$209.22M · buys $0 / sells $209.22M
Range:
Action:
Role:
InsiderRoleAction
2026-04-30EDGEMOND JAMESCFO AND TREASUREROption exercise
10.0K
$135.42$1.35M
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
262
$569.24$149.1K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
484
$570.19$276.0K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
2.9K
$571.23$1.68M
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
3.0K
$572.00$1.74M
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
880
$573.00$504.2K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
887
$574.07$509.2K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
273
$574.96$157.0K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
486
$576.24$280.1K
2026-04-30EDGEMOND JAMESCFO AND TREASURERSell (open market)
336
$577.24$194.0K
1–10 of 500
Page 1 / 50